Trial NCT02925533

View at ClinicalTrials.gov 
Org. Study IDs: 16-246

Last trial update was posted on 2017-06-27

MeSH Interventions

Pembrolizumab

MeSH Conditions

Carcinoma, Transitional Cell Urinary Bladder Neoplasms

Other Conditions

Bladder Cancer

Stopping Reasons

Terminated due to safety concerns.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID